Skip to search boxSkip to navigationSkip to main content

Molecular characterization of a consistent 4.5-megabase deletion at 4q28 in prostate cancer cells

  • Sei Ichi Matsui
    ,
  • Jeffrey LaDuca
    ,
  • Michael R. Rossi
    ,
  • Norma J. Nowak
    ,
  • John K. Cowell(corresponding author)
*Corresponding author for this work
  • Roswell Park Cancer Institute
    ,
  • SUNY Buffalo
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Spectral karyotyping of prostate cell lines LNCaP, DU145, PC3, and 22RV demonstrated structural chromosome rearrangements involving the distal long arm of chromosome 4. In all but 22RV, these are nonreciprocal translocations between chromosomes 4 and 10. In 22RV, an apparently reciprocal t(2q;4q) is seen. Fluorescence in situ hybridization analysis of the chromosome 4 translocation breakpoints demonstrated that deletions were associated with all of the translocations, resulting in a net loss of chromosome material. Overlapping deletions in 4q28∼34 were seen in LNCap, DU145, and 22RV, which defined an approximately 4.5-megabase pair common region of deletion. The deletion in PC3 was more proximal on 4q, involving the 4q21∼q26 region. A meta analysis of high-resolution definition of losses of chromosome material from published studies demonstrates that loss of 4q material may occur in at least 50% of primary tumors. This analysis defines a series of genes in the critical 4q region, which is potentially associated with prostate tumor development.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 18-26 (9 pages)

Journal (Volume, Issue Number)

Cancer Genetics and Cytogenetics (Volume 159, Issue 1)

Publication milestones

  • Published - 05/2005

Publication status

Published - 05/2005

ISSN

0165-4608

Publication IDs

  • Scopus: 18144367648
  • PubMed: 15860352

Publication metrics

Metrics

SciVal
citations
12
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
Scopus
citations
SciVal
FWCI
0.29
SciVal
Author count
5
SciVal
Paper percentile
64

PlumX, opens in new tab

Captures
6
Citation count
12

Funding Details

This work was supported in part by the Roswell Park Cancer Institute's NCI Cancer Center Support grant (CA 16056). We would like to thank Dr. Jin Tang Dong for providing cell line 22RV, as well as Jeffrey Conroy, Devin McQuaid, and Y.D. Wang for the CGHa analysis.
FundersFunding number
NCI
P30CA016056
RPCI
-